News

TRYVIO/JERAYGO Positioned to Redefine Treatment of Resistant Hypertension | DelveInsight
DelveInsight's "TRYVIO/JERAYGO Market Size, Forecast, and Market Insight Report" highlights the details around TRYVIO/JERAYGO ...
DelveInsight Business Research, LLP: TRYVIO/JERAYGO Positioned to Redefine Treatment of Resistant Hypertension | DelveInsight
TRYVIO (aprocitentan) in the US and JERAYGO in Europe present significant market potential as novel therapies for patients with hypertension inadequately controlled by existing treatments. TRYVIO ...